awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27853085-E79E88A0-4A0A-4A50-8B32-6D92D754B8A5
Q27853085-E79E88A0-4A0A-4A50-8B32-6D92D754B8A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853085-E79E88A0-4A0A-4A50-8B32-6D92D754B8A5
Resistant mutations in CML and Ph(+)ALL - role of ponatinib.
P2860
Q27853085-E79E88A0-4A0A-4A50-8B32-6D92D754B8A5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853085-E79E88A0-4A0A-4A50-8B32-6D92D754B8A5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
611198a00d94e66116c7feac113228936c47ff7a
P2860
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants.